home / stock / dva / dva news


DVA News and Press, DaVita Inc. From 11/01/21

Stock Information

Company Name: DaVita Inc.
Stock Symbol: DVA
Market: NYSE
Website: davita.com

Menu

DVA DVA Quote DVA Short DVA News DVA Articles DVA Message Board
Get DVA Alerts

News, Short Squeeze, Breakout and More Instantly...

DVA - The American Diabetes Association® and DaVita Raise Awareness about the Link between Diabetes and Kidney Disease during American Diabetes Month®

The American Diabetes Association® and DaVita Raise Awareness about the Link between Diabetes and Kidney Disease during American Diabetes Month® Collaborative effort helps people take steps to better manage their diabetes and kidney health PR Newswire ...

DVA - DaVita Inc (DVA) Q3 2021 Earnings Call Transcript

Image source: The Motley Fool. DaVita Inc (NYSE: DVA) Q3 2021 Earnings Call Oct 28, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita Inc (DVA) Q3 2021 Earnings Call Transcript

DVA - DaVita's (DVA) CEO Javier Rodriguez on Q3 2021 Results - Earnings Call Transcript

DaVita Inc.'s (DVA) Q3 2021 Earnings Conference Call October 28, 2021 05:00 PM ET Company Participants Jim Gustafson - Vice President of Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Justin Lake - Wolfe Resea...

DVA - DaVita shares fall after Q3 results, FY forecast

DaVita (NYSE:DVA) shares fell over 4% post market after the company reported third-quarter results and provided an update on its FY financial forecast. The company cut the higher end of its FY adjusted profit per share forecast to a range of $8.80-$9.15, compared to a prior guidance...

DVA - DaVita HealthCare Partners EPS beats by $0.10, beats on revenue, narrows guidance range

DaVita HealthCare Partners (NYSE:DVA): Q3 Non-GAAP EPS of $2.36 beats by $0.10; GAAP EPS of $2.36 beats by $0.17. Revenue of $2.94B (+0.7% Y/Y) beats by $30M. 2021 Guidance: Adjusted EPS to range between $8.80-$9.15,  compared to prior guidance of 8.80-$9.40 vs. consensus of $9.18 Press ...

DVA - DaVita Inc. 3rd Quarter 2021 Results

DaVita Inc. 3rd Quarter 2021 Results PR Newswire DENVER , Oct. 28, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2021. "The third quarter was another strong quarter for DaV...

DVA - Renalytix Reports Full Year Fiscal 2021 Results

LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based...

DVA - DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021

DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021 PR Newswire DENVER , Oct. 19, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will host a virtual Capital Markets Day on Tuesday, November 16, 2021 , from ...

DVA - DaVita Inc. Schedules 3rd Quarter 2021 Investor Conference Call

DaVita Inc. Schedules 3rd Quarter 2021 Investor Conference Call PR Newswire DENVER , Oct. 19, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, O...

DVA - IBB: Healthcare Dashboard For October

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IBB. A list of cheap stocks. For further details see: IBB: Healthcare Dashboard For October

Previous 10 Next 10